Medicine HSN Code: GST Rate, Classification & Invoicing Guide for Businesses

Tallysolutions

Tally Solutions

Jul 13, 2026

30 second summary | The HSN code for medicines is used to classify pharmaceutical products for GST compliance, invoicing and tax reporting. Most medicines fall under HSN Chapter 30. From 22 September 2025, most medicines attract 5% GST, while 37 specified life-saving medicines are exempt from GST.

The HSN (Harmonised System of Nomenclature) code for medicines is used to classify pharmaceutical products under Goods and Services Tax (GST), determine the applicable tax rate and ensure accurate invoicing and tax compliance. Most medicines are classified under HSN Chapter 30, Pharmaceutical Products, with specific headings covering medicaments, vaccines, blood products, surgical materials and other pharmaceutical preparations.

The applicable GST rate depends on the product's HSN classification and the relevant government notifications.

What is the HSN code for medicines?

Chapter 30 of the HSN/customs tariff is broken into headings based on the nature of the product. Here are the details:

Description

HSN code

Glands and other organs, dried, whether or not powdered, for organo-therapeutic uses; extracts of glands, other organs or their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included

3001

Extracts of glands or other organs or their secretions

3001 20

Liquid liver extracts

3001 20 10

Dry liver extracts

3001 20 20

Snake venom

3001 20 30

Other

3001 20 90

Other

3001 90

Of human origin

3001 90 10

Heparin and its salts

3001 90 91

Other

3001 90 99

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions; modified immunological products, whether or not obtained or modified through biotechnological processes; vaccines; toxins; cultures of micro-organisms (excluding yeasts) and similar products

3002

Antisera, other blood fractions and immunological products, whether or not modified or obtained through biotechnological processes

3002 10

Malaria diagnostic test kits

3002 11 00

Antisera and other blood fractions

3002 12

Antisera for diphtheria

3002 12 10

Antisera for tetanus

3002 12 20

Antisera for rabies

3002 12 30

Antisera for snake venom

3002 12 40

Other antisera and blood fractions

3002 12 90

Unmixed immunological products, not put up in measured doses or in forms or packings for retail sale

3002 13

Unmixed immunological products, not put up in measured doses or in forms or packings for retail sale

3002 13 10

Mixed immunological products, not put up in measured doses or in forms or packings for retail sale

3002 14

Mixed immunological products, not put up in measured doses or in forms or packings for retail sale

3002 14 10

Immunological products put up in measured doses or in forms or packings for retail sale

3002 15 00

Other

3002 19 00

Vaccines for human medicine

3002 20

Single vaccines

3002 20

Single vaccine for cholera and typhoid

3002 20 11

Single vaccine for hepatitis

3002 20 12

Single vaccine for tetanus

3002 20 13

Single vaccine for polio

3002 20 14

Single vaccine for tuberculosis

3002 20 15

Single vaccine for rabies

3002 20 16

Single vaccine for Japanese encephalitis

3002 20 17

Single vaccine for whooping cough (pertussis)

3002 20 18

Other single vaccines

3002 20 19

Mixed vaccines

3002 20

Mixed vaccine for diphtheria, pertussis and tetanus (DPT)

3002 20 21

Mixed vaccine for diphtheria and tetanus (DT)

3002 20 22

Mixed vaccine for measles, mumps and rubella (MMR)

3002 20 23

Mixed vaccine for typhoid-paratyphoid (TAB) or typhoid-paratyphoid-cholera (TABC)

3002 20 24

Other mixed vaccines

3002 20 29

Vaccines for veterinary medicine

3002 30 00

Other

3002 90

Human blood

3002 90 10

Animal blood prepared for therapeutic, prophylactic or diagnostic uses

3002 90 20

Cultures of micro-organisms (excluding yeast)

3002 90 30

Toxins

3002 90 40

Other

3002 90 90

Medicaments (excluding goods of headings 3002, 3005 or 3006) consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale

3003

Medicaments containing penicillins or their derivatives with a penicillanic acid structure, or streptomycins or their derivatives

3003 10 00

Other medicaments containing antibiotics

3003 20 00

Medicaments containing hormones or other products of heading 2937

3003

Medicaments containing insulin

3003 31 00

Other medicaments containing hormones or other products of heading 2937

3003 39 00

Medicaments containing alkaloids or their derivatives

3003

Medicaments containing ephedrine or its salts

3003 41 00

Medicaments containing pseudoephedrine (INN) or its salts

3003 42 00

Medicaments containing norephedrine or its salts

3003 43 00

Other medicaments containing alkaloids or their derivatives

3003 49 00

Medicaments containing active antimalarial principles described in Sub-heading Note 2 to this Chapter

3003 60 00

Other medicaments

3003 90

Medicaments of the Ayurvedic system

3003 90 11

Medicaments of the Unani system

3003 90 12

Medicaments of the Siddha system

3003 90 13

Medicaments of the Homoeopathic system

3003 90 14

Medicaments of the Bio-chemic system

3003 90 15

Menthol crystals

3003 90 21

Milk of magnesia

3003 90 22

Bovine albumin and drugs of animal origin

3003 90 31

Merbromine National Formulary XII (Mercurochrome)

3003 90 32

Calcium sennoside

3003 90 33

Anaesthetic agents used in human or veterinary medicine or surgery

3003 90 34

Aluminium hydroxide gel

3003 90 35

Ketamine

3003 90 36

Other medicaments

3003 90 90

What GST rate applies to medicines?

From 22 September 2025, most medicines will attract 5% GST, following recommendations from the 56th GST Council Meeting. In addition, 37 specified life-saving medicines, including those used to treat cancer, rare diseases and certain chronic conditions, are exempt from GST (Nil rate).

The government retained a 5% GST on most medicines rather than fully exempting them, so manufacturers can continue to claim input tax credit (ITC). This helps reduce production costs and limits the impact of tax costs on medicine prices.

Note: While most medicines now fall under the 5% GST rate, a few pharmaceutical or pharma-adjacent products continue to attract the 18% GST rate. One commonly cited example is nicotine polacrilex gum, which falls outside the standard medicine category.

What are the HSN code requirements on GST invoices?

The HSN code required on a GST invoice depends on your Aggregate Annual Turnover (AATO) in the preceding financial year. Businesses must print the prescribed number of HSN digits on invoices and report them in GST returns in accordance with CBIC Notification No. 78/2020-Central Tax.

Aggregate Annual Turnover (AATO) in the preceding FY

HSN digits required on invoices

Up to ₹5 crore

4-digit HSN mandatory on B2B invoices; optional on B2C

Above ₹5 crore

6-digit HSN mandatory on all invoices, B2B and B2C

Exports / imports

Full 8-digit HSN required to align with customs classification

A few compliance details that pharma businesses frequently get wrong:

  • Table 12 of GSTR-1 is mandatory for all taxpayers: Since 1 January 2024, all registered taxpayers must report HSN-wise details in Table 12 of GSTR-1, regardless of turnover.
  • HSN codes must be selected from the GST portal: Under the Phase 3 rollout, manual entry of HSN codes and descriptions is no longer permitted. Taxpayers must select a valid HSN code from the portal's dropdown list, after which the description is auto-populated.
  • B2B and B2C supplies are reported separately: Table 12 contains separate sections for B2B and B2C transactions, and the GST portal validates these values against other GSTR-1 tables before submission.
  • Composition taxpayers must also report HSN codes: Although composition dealers issue a Bill of Supply instead of a tax invoice, they must comply with the applicable HSN digit requirement based on their turnover.
  • HSN digit requirements are based on the previous financial year's AATO: The applicable 4-digit or 6-digit requirement remains unchanged throughout the year, even if turnover changes.
  • Table 13 document reporting is mandatory where applicable: Taxpayers reporting B2B or B2C supplies must also complete the required document details in Table 13.

What should pharma businesses check before issuing a GST invoice?

To prepare a GST-compliant invoice for medicines, verify the following before issuing the invoice:

  • Use the correct HSN code at the applicable digit level (4, 6 or 8 digits) based on your turnover and the nature of the transaction.
  • Verify the applicable GST rate against the specific HSN tariff item. Do not assume all products under the same 4-digit HSN heading attract the same GST rate, as nil-rated, 5% and 18% items may coexist.
  • Apply the correct GST type: Charge CGST and SGST for intra-state supplies, and IGST for inter-state supplies and exports.
  • Maintain accurate product classification: Record brand status and packaging, as these may affect the classification of Ayurvedic, Unani and Siddha medicines.
  • Follow the revised pricing guidance: Following the September 2025 GST rate change, medicines already released into the market before 22 September 2025 did not require MRP re-labelling, provided manufacturers and marketing companies ensured price compliance through approved measures such as supplementary price lists.
  • Claim ITC correctly: ITC is generally available on taxable supplies but not on nil-rated or exempt supplies. Businesses making exempt supplies may also need to reverse proportionate ITC on common inputs, where applicable.

What is the penalty for incorrect invoicing

Incorrect invoicing can attract a general penalty of up to ₹25,000 under Section 125 of the CGST Act, depending on the nature of the non-compliance. In addition, using an incorrect HSN code on a B2B invoice can delay or deny the buyer's ITC claim until the error is corrected, even though the mistake originated with the seller.

Conclusion

Using the correct HSN code for medicines is essential for accurate GST classification, invoicing and tax reporting. Regularly reviewing product classifications, applying the correct GST rates and following HSN reporting requirements can help businesses avoid compliance issues, minimise reconciliation errors and maintain accurate financial records.

TallyPrime simplifies HSN-based invoicing, GST reporting and inventory management, enabling pharma businesses to manage compliance efficiently while supporting smoother day-to-day operations.

Published on July 13, 2026

left-icon
1

of

4
right-icon

India’s choice for business brilliance

Work faster, manage better, and stay on top of your business with TallyPrime, your complete business management solution.

Get 7-days FREE Trial!

I have read and accepted the T&C
Submit